Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arthralgia × Aromatase Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Neoplasm Metastasis 2 Luminal B/HER2-negative Breast Cancer 1 Hormone Receptor Positive Breast Carcinoma 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Cancer Female 1 Arthralgia 1 Advanced Breast Cancer 1

Interventions

Therapeutics 1 Testosterone 1 Surveys and Questionnaires 1 Letrozole 1 Hyaluronic Acid 1 Glucosamine 1 Glucaric Acid 1 Chondroitin Sulfates 1 Chondroitin 1 Cholecalciferol 1 Cannabidiol 1 Calcium Gluconate 1 Calcium Citrate 1 Calcium Carbonate 1 Calcium 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01612728 2013-02-12

AIA

Baylor Breast Care Center

Phase 2 Withdrawn

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡